[Elite controller cured of hepatitis C virus after 14 weeks of telaprevir-based triple therapy]

Rev Chilena Infectol. 2015 Aug;32(4):486. doi: 10.4067/S0716-10182015000500022.
[Article in Spanish]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acquired Immunodeficiency Syndrome / virology*
  • Adult
  • Coinfection / virology
  • HIV-1*
  • Hepatitis C / drug therapy*
  • Humans
  • Male
  • Oligopeptides / therapeutic use*
  • Serine Proteinase Inhibitors / therapeutic use*
  • Time Factors
  • Treatment Outcome
  • Viral Load*

Substances

  • Oligopeptides
  • Serine Proteinase Inhibitors
  • telaprevir